Cent Eur J Public Health 2011, 19(1):26-29 | DOI: 10.21101/cejph.a3602
Hepatitis C Virus Antibody Status, Sociodemographic Characteristics, and Risk Behaviour among Injecting Drug Users in Croatia
- 1 Department of Virology, Croatian National Institute of Public Health, Zagreb, Croatia
- 2 School of Medicine, University of Zagreb, Croatia
- 3 Zagreb County Institute of Public Health, Velika Gorica, Croatia
- 4 School of Medicine, University of Rijeka, Croatia
The study was conducted among 76 injecting drug users (IDU) from seven Croatian cities during a three-year period (2005-2007). Each par-ticipant completed a questionnaire on sociodemographic characteristics and potential risk factors for hepatitis C virurs (HCV) infection followed by anti-HCV and anti-HIV antibody testing. The mean patient age was 30. The majority of patients (69.8%) reported more than one potential exposure to HCV: 97.1% had shared injecting equipment, 75% reported risk sexual behaviour, and 56.3% reported a history of travelling abroad. The overall HCV seroprevalence was 51.3% (95% CI=40-63%). HCV seroprevalence increased with increasing number of risk behaviours (p=0.026). Needle sharing frequency was the most important risk factor for hepatitis C. The HCV seroprevalence rate ranged from 27.3% in IDUs who answered that they shared needles occasionally to 100% in IDUs who always shared needles (p<0.001). No other risk factors (age, gender, educational level, marital and employment status, history of travelling abroad and sexual risk behaviour) were associated with HCV seropositivity.
Keywords: hepatitis C, IDU, seroprevalence, risk factors
Received: December 18, 2009; Revised: October 4, 2010; Accepted: October 4, 2010; Published: March 1, 2011 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999 Jan;6(1):35-47.
- Thorpe LE, Ouellet LJ, Hershow R, Bailey SL, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol. 2002 Apr 1;155(7):645-53.
Go to original source...
- Merkinaite S, Lazarus JV, Gore C.Addressing HCV infection in Europe: reported, estimated and undiagnosed cases. Cent Eur J Public Health. 2008 Sep;16(3):106-10.
Go to original source...
- Kyrychenko PD. Seroprevalence of HIV and HCV markers among injection drug users seeking medical care. In: 15th International conference on AIDS; 2004 Jul 11-16; Bangkok, Thailand. Bangkok: 2004; abstract no. MoPeC3526.
- Vassilev ZP, Hagan H, Lyubenova A, Tomov N, Vasilev G, Krasteva D, et al. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users. Int J STD AIDS. 2006 Sep;17(9):621-6.
Go to original source...
Go to PubMed...
- Smyth BP, Barry J, Keenan E. Irish injecting drug users and hepatitis C: the importance of the social context of injecting. Int J Epidemiol. 2005 Feb;34(1):166-72.
Go to original source...
Go to PubMed...
- Hickman M, HopeV, BradyT, Madden P, Jones S, Honor S, et al. Hepatitis C virus (HCV) prevalence, and injecting risk behaviour in multiple sites in England in 2004. J Viral Hepat. 2007 Sep;14(9):645-52.
Go to original source...
Go to PubMed...
- Vicente J, Wiessing L; EMCDDA, national focal points and expert networks. European Monitoring Centre for Drugs and Drug Addiction annual report 2007: positive assessment of HIV in IDUs though hepatitis C still very high. Euro Surveill. 2007 Nov 22;12(11):E071122.6.
Go to original source...
- Jadoul M, Poignet JL, Geddes C, Locatelli F, Medin C, Krajewska M, et al; HCV Collaborative Group. The changing epidemiology of hepatitis C virus (HCV) infection in haemodialysis: European multicentre study. Nephrol Dial Transplant. 2004 Apr;19(4):904-9.
Go to original source...
Go to PubMed...
- OlutAI, Ozsakarya F, Dilek M. Seroprevalence of hepatitis C virus infection and evaluation of serum aminotransferase levels among haemodialysis patients in Izmir, Turkey. J Int Med Res. 2005 Nov-Dec;33(6):641-6.
Go to original source...
Go to PubMed...
- World HepatitisAwareness Day, 2007. HCV infection in Europe. Vilnius: Eurasian Harm Reduction Network; 2007.
- Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan SA. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability. Euro Surveill. 2008 May 22;13(21):pii 18884.
Go to original source...
- Xia X, Luo J, Bai J, Yu R. Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health. 2008 Oct;122(10):990-1003.
Go to original source...
Go to PubMed...
- Thomas DL, Zenilman JM, Alter HJ, Shih JW, Galai N, Carella AV, et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore: an analysis of 309 sex partnerships. J Infect Dis. 1995 Apr;171(4):768-75.
Go to original source...
- Wejstål R. Sexual transmission of hepatitis C virus. J Hepatol. 1999;31 Suppl 1:92-5.
Go to original source...
Go to PubMed...
- Cavlek TV, Margan IG, Lepej SZ, Kolaric B, Vince A. Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia. J Med Virol. 2009 Aug;81(8):1348-53.
Go to original source...
Go to PubMed...
- Gjenero-Margan I, Kolarić B. Epidemiology of HIV infection andAIDS in Croatia - an overview. Coll Antropol. 2006 Dec;30 Suppl 2:11-6.
Go to PubMed...
- Kolarić B, Štajduhar D, Gajnik D, Rukavina T, Wiessing L. Seroprevalence of blood-borne infections and population sizes estimates in a population of injecting drug users in Croatia. Cent Eur J Public Health. 2010 Jun;18(2):104-9.
Go to original source...
- Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, et al. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006 Jun;74(6):1111-6.
Go to original source...
- Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol. 2004 Feb;33(1):182-8.
Go to original source...
Go to PubMed...
- Hershow RC, Kalish LA, Sha B, Till M, Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov;25(10):527-32.
Go to original source...
Go to PubMed...
- Barros H, Ramos E, Lucas R. A survey of HIV and HCV among female prison inmates in Portugal. Cent Eur J Public Health. 2008 Sep;16(3):11620.
Go to original source...
- Medić A, Dželalija B, Sonicki Z, Zekanović D. Characteristics of hepatitis C infection in injecting drug users in Zadar County, Croatia. Coll Antropol. 2008 Sep;32(3):697-702.
Go to PubMed...
- WongT, Lee SS. Hepatitis C: a review for primary care physicians. CMAJ. 2006 Feb 28;174(5):649-59.
Go to original source...
- Hahn JA, Page-Shafer K, Ford J, Paciorek A, Lum PJ. Traveling young injection drug users at high risk for acquisition and transmission of viral infections. Drug Alcohol Depend. 2008 Jan 11;93(1-2):43-50.
Go to original source...
Go to PubMed...